Clinical Trials Logo

Clinical Trial Summary

Brucellosis is a common zoonotic infection in many parts of the world including the Mediterranean and Middle Eastern countries.

Neurobrucellosis may develop at any stage of disease and may have widely variable manifestations, including encephalitis, meningoencephalitis, radiculitis, myelitis, peripheral and cranial neuropathies, subarachnoid hemorrhage, and psychiatric manifestations.


Clinical Trial Description

Brucellosis is a common zoonotic infection in many parts of the world including the Mediterranean and Middle Eastern countries.

Neurobrucellosis may develop at any stage of disease and may have widely variable manifestations, including encephalitis, meningoencephalitis, radiculitis, myelitis, peripheral and cranial neuropathies, subarachnoid hemorrhage, and psychiatric manifestations.

The aimed is to shed light to the obscure areas of diagnosis in neurobrucellosis and have detailed general and neurologic features ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04301752
Study type Observational
Source Mansoura University Hospital
Contact
Status Completed
Phase
Start date February 1, 2019
Completion date March 1, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT04717622 - Investigation of Fever Suspected as a Zoonosis Using Advanced Diagnostic Technologies
Completed NCT04911283 - Brucella Serology and History of Brucellosis in Patients With Modic Changes Type 1
Completed NCT01766830 - Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) N/A
Completed NCT06007326 - A Multicentre, Retrospective Study of Clinical Characteristics and Long-term Outcomes of Patients With Brucellosis